Trial
NCT02508649
Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Ferring Pharmaceuticals
Collaborators
—
Condition
Septic Shock
Intervention
selepressin
Why stopped
Terminated due to futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-06